Follow
Róbert Király
Title
Cited by
Cited by
Year
In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies
IR Korponay-Szabó, T Halttunen, Z Szalai, K Laurila, R Király, JB Kovács, ...
Gut 53 (5), 641-648, 2004
4452004
Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits
TT Salmi, P Collin, IR Korponay-Szabo, K Laurila, J Partanen, H Huhtala, ...
Gut 55 (12), 1746-1753, 2006
3262006
Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+‐dependent action of a multifunctional protein
R Király, MÁ Demény, L Fésüs
The FEBS journal 278 (24), 4717-4739, 2011
1092011
Functional significance of five noncanonical Ca2+‐binding sites of human transglutaminase 2 characterized by site‐directed mutagenesis
R Király, É Csősz, T Kurtán, S Antus, K Szigeti, Z Simon‐Vecsei, ...
The FEBS journal 276 (23), 7083-7096, 2009
992009
Coeliac disease case finding and diet monitoring by point‐of‐care testing
IR KORPONAY‐SZABÓ, T Raivio, K Laurila, J Opre, R Kiraly, JB Kovács, ...
Alimentary pharmacology & therapeutics 22 (8), 729-737, 2005
932005
Transglutaminase 2 in human diseases
Z Szondy, I Korponay-Szabó, R Király, Z Sarang, GJ Tsay
BioMedicine 7 (3), 2017
912017
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects
Z Simon-Vecsei, R Király, P Bagossi, B Tóth, I Dahlbom, S Caja, É Csősz, ...
Proceedings of the National Academy of Sciences 109 (2), 431-436, 2012
772012
Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize
IR Korponay-Szabó, Z Vecsei, R Király, I Dahlbom, F Chirdo, É Nemes, ...
Journal of pediatric gastroenterology and nutrition 46 (3), 253-261, 2008
772008
Coeliac autoantibodies can enhance transamidating and inhibit GTPase activity of tissue transglutaminase: dependence on reaction environment and enzyme fitness
R Király, Z Vecsei, T Deményi, IR Korponay-Szabó, L Fésüs
Journal of autoimmunity 26 (4), 278-287, 2006
602006
Identification of a specific one amino acid change in recombinant human transglutaminase 2 that regulates its activity and calcium sensitivity
K Kanchan, E Ergülen, R Király, Z Simon-Vecsei, M Fuxreiter, L Fésüs
Biochemical Journal 455 (3), 261-272, 2013
392013
Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters
R Király, K Thangaraju, Z Nagy, R Collighan, Z Nemes, M Griffin, L Fésüs
Amino acids 48, 31-40, 2016
312016
Transglutaminase 2 Dysfunctions in the Development of Autoimmune Disorders: Celiac Disease and TG2 / Mouse
Z Szondy, I Korponay‐Szabó, R Király, L Fésüs
Advances in Enzymology: And Related Areas of Molecular Biology 78, 295-345, 2011
212011
Metastasis-associated S100A4 is a specific amine donor and an activity-independent binding partner of transglutaminase-2
B Biri, B Kiss, R Király, G Schlosser, O Láng, L Kőhidai, L Fésüs, L Nyitray
Biochemical Journal 473 (1), 31-42, 2016
192016
Caspase‐9 acts as a regulator of necroptotic cell death
T Molnár, P Pallagi, B Tél, R Király, E Csoma, V Jenei, Z Varga, ...
The FEBS Journal 288 (22), 6476-6491, 2021
182021
Juvenile Huntington’s Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological …
A Aladdin, R Király, P Boto, Z Regdon, K Tar
International journal of molecular sciences 20 (21), 5338, 2019
182019
Irisin Stimulates the Release of CXCL1 From Differentiating Human Subcutaneous and Deep-Neck Derived Adipocytes via Upregulation of NFκB Pathway
A Shaw, BB Tóth, R Király, R Arianti, I Csomós, S Póliska, A Vámos, ...
Frontiers in cell and developmental biology 9, 737872, 2021
142021
Polymorphism of transglutaminase 2: unusually low frequency of genomic variants with deficient functions
R Király, E Barta, L Fésüs
Amino Acids 44, 215-225, 2013
132013
Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction
Á Diós, R Elek, I Szabó, S Horváth, J Gyimesi, R Király, K Werkstetter, ...
Amino Acids 53 (7), 1051-1063, 2021
82021
Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2
K Thangaraju, R Király, MA Demeny, J András Mótyán, M Fuxreiter, ...
PloS one 12 (3), e0172189, 2017
82017
Computational analyses of the effect of novel amino acid clusters of human transglutaminase 2 on its structure and function
K Thangaraju, R Király, JA Mótyán, VA Ambrus, M Fuxreiter, L Fésüs
Amino acids 49, 605-614, 2017
72017
The system can't perform the operation now. Try again later.
Articles 1–20